Search

everythinglearnresearchcommunity

for

Search:↓

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

A nurse-led hair service reduced waiting times and improved patient satisfaction and outcomes for alopecia areata treatment.

More research is needed to understand and treat morphea effectively.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Amalaki Churna effectively reduces hair fall and improves hair strength.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Living with metastatic pancreatic cancer involves symptoms like fatigue and nausea, and impacts like anxiety and reduced physical function.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The study created a 27-item measure to assess the impact of skin diseases.

PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

TCM is an effective and safe treatment for primary cicatricial alopecias.